Q2e: 4.0m EEs, 58k SCs pre-announced, expect SEK 13m EBIT. Cut sales by ~4%, EBIT by ~6% on lower EE volume vs. our estimate. End-of-life programme in H2, estimate -10% impact, H2 EEs -2.5%.
Enviable financials: 10% sales and 20% 10-year EPS CAGR. Shunned by funds, but ESG and electrification risks overblown. We forecast 8% sales and 13% EPS CAGR over coming decade.
Strong y-o-y growth: EEs +18%, SCs +36%, sales +22%. EBIT margin 23% (25%), ~33% adjusted for FX effects. End-of-life programme in H2 will be partly offset by others ramping.
Volumes to begin ramping up in newly added foundries ’22 and ’24 series production targets reiterated 21x ’22e EV/EBIT (adj.), 5-8% ’22e-’24e dividend yields